Combination of Apatinib and Transcatheter Arterial Chemotherapy Embolization (TACE) for the Treatment of Liver Metastasis of Gastrointestinal Stromal Tumors: Report of One Rare Case

Xin Liu, Feng Li, Jun Li, Ningfang Wang, Jian Zhang and Feng Wang*

Department of Interventional Therapy, The First Affiliated Hospital of Dalian University, Dalian, China

^*Correspondance to: Jian Zhang 

 PDF  Full Text Case Report | Open Access

Abstract:

Gastrointestinal Stromal Tumor is a type of tumor that originates from mesenchymal tissues of gastrointestinal tract, most commonly in the stomach and small intestine. Apatinib is a small molecule tyrosine kinase inhibitor approved by China Food and Drug Administration in 2014 for the treatment of advanced gastric adenocarcinoma progressed or relapsed after at least two lines of systemic chemotherapy. Transcatheter Arterial Chemotherapy Embolization (TACE) is an important therapy for local treatment of liver tumors. According to the NCCN guidelines, TACE was recommending as a treatment method for locally advanced gastrointestinal stromal tumors

Keywords:

Gastrointestinal stromal tumor; Hepatic metastasis; Transcatheter arterial chemotherapy embolizatio; Apatinib; Anti-angiogenesis

Cite the Article:

Liu X, Li F, Li J, Wang N, Zhang J, Wang F. Combination of Apatinib and Transcatheter Arterial Chemotherapy Embolization (TACE) for the Treatment of Liver Metastasis of Gastrointestinal Stromal Tumors: Report of One Rare Case. Clin Oncol. 2020; 5: 1693.